Abstract
Purpose
Resection is the mainstay of management in patients with sarcoma lung metastases, but there is a limit to how many resections can be performed. Some patients with inoperable disease have small-volume lung metastases that are amenable to thermal ablation. We report our results after radiofrequency ablation (RFA).
Methods
This is a retrospective study of patients treated from 2007 to 2012 in whom the intention was to treat all sites of disease and who had a minimum CT follow-up of 4 months. Treatment was performed under general anesthesia/conscious sedation using cool-tip RFA. Follow-up CT scans were analyzed for local control. Primary tumor type, location, grade, disease-free interval, prior resection/chemotherapy, number and size of lung tumors, uni- or bilateral disease, complications, and overall and progression-free survival were recorded.
Results
Twenty-two patients [15 women; median age 48 (range 10–78) years] with 55 lung metastases were treated in 30 sessions. Mean and median tumor size and initial number were 0.9 cm and 0.7 (range 0.5–2) cm, and 2.5 and 1 (1–7) respectively. Median CT and clinical follow-up were 12 (4–54) and 20 (8–63) months, respectively. Primary local control rate was 52 of 55 (95 %). There were 2 of 30 (6.6 %) Common Terminology Criteria grade 3 complications with no long-term sequelae. Mean (median not reached) and 2- and 3-year overall survival were 51 months, and 94 and 85 %. Median and 1- and 2-year progression-free survival were 12 months, and 53 and 23 %. Prior disease-free interval was the only significant factor to affect overall survival.
Conclusion
RFA is a safe and effective treatment for patients with small-volume sarcoma metastases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tascilar M, Loos WJ, Seynaeve C et al (2007) The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas. Oncologist 12:1351–1360
Rehders A, Hosch SB, Scheunemann P et al (2007) Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg 142:70–75
Casiraghi M, De Pas T, Maisonneuve P et al (2011) A 10-year single-center experience on 708 lung metastasectomies: the evidence of the International Registry of Lung Metastases. J Thorac Oncol 6:1373–1378
Predina JD, Puc MM, Bergey MR et al (2011) Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol 6:913–919
Hornbech K, Ravn J, Steinbruchel DA (2011) Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections, 2002–2006. J Thorac Oncol 6:1733–1740
Pfannschmidt J, Klode J, Muley T et al (2006) Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients. Thorac Cardiovasc Surg 54:489–492
Gillams AR, Lees WR (2008) Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 18:672–677
Nakamura T, Matsumine A, Yamakado K et al (2009) Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected]. Cancer 115:3774–3781
Palussiere J, Italiano A, Descat E et al (2011) Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients. Ann Surg Oncol 18:3771–3777
Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 32:478–483
Bielack SS, Kempf-Bielack B, Branscheid D et al (2009) Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 27:557–565
Liebl LS, Elson F, Quaas A et al (2007) Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. Anticancer Res 27:2897–2902
Lencioni R, Crocetti L, Cioni R et al (2008) Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9:621–628
Tada A, Hiraki T, Iguchi T et al (2012) Influence of radiofrequency ablation of lung cancer on pulmonary function. Cardiovasc Intervent Radiol 35:860–867
Kim S, Ott HC, Wright CD et al (2011) Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg 92:1780–1786
Smith R, Pak Y, Kraybill W et al (2009) Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 35:356–361
Ellis MC, Hessman CJ, Weerasinghe R et al (2011) Comparison of pulmonary nodule detection rates between preoperative CT imaging and intraoperative lung palpation. Am J Surg 201:619–622
Dhakal S, Corbin KS, Milano MT et al (2012) Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys 82:940–945
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koelblinger, C., Strauss, S. & Gillams, A. Outcome after Radiofrequency Ablation of Sarcoma Lung Metastases. Cardiovasc Intervent Radiol 37, 147–153 (2014). https://doi.org/10.1007/s00270-013-0644-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0644-9